Different Types of Circulatory Inflammatory Biomarkers Associated with Cerebral Arterial Atherosclerosis and

Yuan Cao1, Ding-Ding Zhang2, Jing-Yu Mu3

  • 1Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, caoyuan0725@gmail.com.

Insights

This study found that different inflammatory biomarkers are linked to specific types of cerebral large vessel diseases, suggesting distinct inflammatory pathways. Understanding these differences may lead to targeted anti-inflammatory therapies for atherosclerosis and dolichoectasia.

Area of Science:

  • Neurology
  • Inflammation Research
  • Vascular Biology

Background:

  • Inflammation is implicated in arteriopathy, but specific biomarker links to cerebral large vessel diseases are unclear.
  • Cerebral large vessel diseases, including atherosclerosis and dolichoectasia, pose significant health risks.

Purpose of the Study:

  • To investigate the association between various inflammatory biomarkers and cerebral atherosclerosis and dolichoectasia.
  • To differentiate the roles of systemic, endothelial-related, and media-related inflammation in these vascular conditions.

Main Methods:

  • Analysis of 14 circulatory inflammatory biomarkers in 960 participants from the Shunyi study.
  • Assessment of intracranial atherosclerotic stenosis (ICAS), dolichoectasia, and carotid plaques using advanced imaging techniques.
  • Grouping biomarkers based on inflammatory cascades: systemic, endothelial-related, and media-related.

Main Results:

  • The endothelial-related inflammatory group showed significant associations with ICAS and carotid plaques, with E-selectin being a prominent biomarker.
  • The systemic inflammatory group was linked to increased basilar artery diameter, with IL-6 identified as a key contributor.
  • These findings indicate distinct inflammatory profiles for different types of cerebral large vessel diseases.

Conclusions:

  • Specific inflammatory biomarkers are differentially associated with cerebral atherosclerosis and dolichoectasia.
  • These distinct associations suggest unique underlying inflammatory processes for each condition.
  • Further research into the anti-inflammatory roles of these biomarkers is warranted for potential therapeutic targeting.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
59
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
69
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
244
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
163
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
142
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
44